Search for: "THE PROCTER " Results 141 - 160 of 1,559
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2020, 1:04 pm by Susan Letterman White
 Maslow’s hierarchy of needs (physiological needs; safety needs; social needs; esteem needs; self-actualization) is discussed in Procter & Gamble branding expert Carolina Rogol’s book, Star Brands. [read post]
17 Aug 2020, 1:15 pm by Gene Quinn
U.S. companies, including Apple, Ford, Walmart, Walt Disney, Procter & Gamble and Intel “are concerned the administration’s action could effectively cut them off from access to the lucrative China market, for example by ending their ability to accept payments or advertise on WeChat. [read post]
17 Aug 2020, 1:15 pm by Gene Quinn
U.S. companies, including Apple, Ford, Walmart, Walt Disney, Procter & Gamble and Intel “are concerned the... [read post]
6 Aug 2020, 5:24 pm by Doug Cornelius
One caught my eye and caught the eye of Goodwin Procter lawyers Peter W. [read post]
23 Jul 2020, 2:55 pm by Kevin LaCroix
I have been joined in these recorded sessions by my good friends Carl Metzger of the Goodwin Procter law firm and Rob Yellen of Willis Towers Watson. [read post]
20 Jul 2020, 2:42 pm by Kevin LaCroix
The other companies are in a wide variety of other industries, such as Procter and Gamble, CSX, and The TJX Companies. [read post]
5 Jul 2020, 5:43 am by Annsley Merelle Ward
  John was heavily involved in the IP Federation as the former VP of Patents EMEA at Procter & Gamble in the late 1990s and early 00s. [read post]
8 Jun 2020, 10:13 am by Schachtman
Claims under Federal and State Racketeering Acts And Other Civil Remedies There are three types approaches to civil remedies a defendant might pursue to inhibit the flow of false claims in products cases. [read post]
11 May 2020, 2:57 pm by Kevin LaCroix
I have been joined in these recorded sessions by my good friends Carl Metzger of the Goodwin Procter law firm and Rob Yellen of Willis Towers Watson. [read post]
8 May 2020, 5:58 am
Public Company Compensation Committees in Light of COVID-19 Posted by Lynda Galligan and Alexandra Denniston, Goodwin Procter LLP, on Friday, May 1, 2020 Tags: COVID-19, Disclosure, Equity-based compensation, Executive Compensation, Incentives, Management, Pay for performance, Performance measures, Repricings, Section 162(m), Stock options, Succession A New Era For Activist Defense: Going Beyond the Relics of the 80s… [read post]
2 May 2020, 8:06 pm by Patent Docs
Ken Corsello of IBM; Cathy Lui of Orrick Herrington & Sutcliffe; Jim Pooley, Chair of the Sedona Conference Working Group 12 on Trade Secrets; and Rachel Walsh of Goodwin Procter will provide tips and insights on basic trade secret management practices and how they can be adapted for the current environment. [read post]
27 Apr 2020, 2:29 pm by Kevin LaCroix
According to an April 22, 20202 report from the Goodwin Procter law firm entitled “Update on Securities Litigation Against Cannabis Companies” (here), the number of securities suits against cannabis companies jumped significantly in 2019 compared to 2018. [read post]
10 Apr 2020, 4:04 pm by Joe Patrice
Hodgson Russ, Fisher & Phillips, Goodwin Procter, Mintz Levin, and Baker McKenzie. [read post]
3 Apr 2020, 2:25 pm by Kevin LaCroix
Three weeks ago, as part of a Professional Liability Underwriting Society (PLUS) series of recorded discussions on the professional liability insurance implications of the COVID-19 Coronavirus outbreak, I participated in a short recorded conversation on the viral outbreak’s D&O insurance implications with my good friends Carl Metzger of the Goodwin Procter law firm and Rob Yellen of Willis Towers Watson. [read post]
25 Mar 2020, 2:00 am by Rose Hughes
To date, the case law on whether such selections are permissible has not been consistent (see T 2273/10, T 2237/10).Convergent versus non-convergent listsThe recently published appeal decision T 1621/16 concerned Procter & Gamble's patent EP 2264138. [read post]
11 Mar 2020, 1:21 pm by Kevin LaCroix
Joining me for the conversation were my good friends Carl Metzger of the Goodwin Procter law firm and Rob Yellen of Willis Towers Watson. [read post]
28 Feb 2020, 1:32 am
MicrobeCase Background: Disinfection and antimicrobial activityThe case in T 1385/15 related to an appeal from the decision of the Opposition Division to revoke Procter and Gamble's patent EP 1865998. [read post]
19 Feb 2020, 11:36 am
Technology and life sciences deals continue to drive big gains for Goodwin, which boosted revenue by 11% last year. [read post]